Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...
Investor's Business Daily on MSN
Why Immunome, a top 3% stock, just rocketed on its rivalry with Merck KGaA
Top-notch biotech stock Immunome rocketed Monday after the company's treatment for desmoid tumors appeared to top an approved ...
Many patients with inflammatory bowel disease (IBD) suffer from abdominal pain even between acute inflammatory flare-ups.
WHEN Ciára McManigan was given “48 hours to live” she thought back to her GP telling her she just had a case of piles. “My ...
Gastroenterology is heading into a turbulent year as site-of-care shifts, evolving technology and economic pressures collide with rising demand and complexity. Five disruptions in particular are ...
Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to ...
Gastrointestinal Diagnostics Market Gastrointestinal Diagnostics Market Dublin, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The ...
Recent research has identified practical ways to protect and deliver oxygen-sensitive gut bacteria for a path toward safer, ...
Here’s a closer look at the top pharmaceutical companies that have earned favorable rankings from Wolfe Research analysts. Johnson & Johnson takes the top spot with growth primarily driven by new ...
Investing.com -- Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock jumped 5.1% Monday after the company announced it submitted a Biologics License Application (BLA) to the FDA for imsidolimab, a treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback